FDA advisory panel narrowly endorses Mercks oral Covid treatment pill, despite reduced efficacy and safety questions – CNBC

A Food and Drug Administration advisory panel on Tuesday narrowly endorsed the uPse of Merck and Ridgeback Biotherapeutics’ oral Covid treatment pill, despite questions about the drug’s effectiveness… [+8749 chars]